Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
December 2018
EMJ Oncology 6.1 2018
Supplemented by summaries of a selection of ESMO abstract presentations, EMJ’s Oncology eJournal provides a comprehensive summary of the 5 days in Munich…
2
Mins
6 Dec 2018
First In-Human Study with GSK3359609, an Inducible T cell Costimulator Receptor Agonist in Patients with Advanced, Solid Tumours: Preliminary Results from INDUCE-1
Inducible T cell costimulator (ICOS), a member of the CD28/B7 receptor superfamily, is expressed on T cells after T cell receptor engagement with cognate…
6 Dec 2018
Prof Ahmad Awada
Head of the Medical Oncology and Medicine Department, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium…
9
Mins
6 Dec 2018
The Right Therapy Starts with the Right Test: Novel Therapeutic Approaches in Oncology Foster the Need for an Appropriate Molecular Profiling Strategy
Adding a molecular perspective to the traditional multidisciplinary management of cancer patients is substantially hampering the adoption of precision…
1
Mins
6 Dec 2018
Preliminary Safety, Efficacy, and Pharmacokinetic and Pharmacodynamic Characterisation from GARNET, a Phase I Clinical Trial of the Anti-PD-1 Monoclonal Antibody TSR-042 in Patients with Recurrent or Advanced Microsatellite Instability-High Endometrial Cancer
At the European Society for Medical Oncology (ESMO) 2018 Congress, data from the ongoing Phase I clinical trial of the anti-programmed death…
8
Mins
6 Dec 2018
Prediction with Precision: Does TAILORx Make Chemotherapy a Personalised Treatment?
Adjuvant chemotherapy (CT) is commonly recommended to breast cancer patients following surgery. However, not all patients benefit from it, and the…
5
Mins
6 Dec 2018
Congress Feature from ESMO 2018
During this year’s ESMO Congress, the EMJ team attended the three hotly- anticipated Presidential Symposia chaired by ESMO President Prof Josep Tabernero…
1
Mins
6 Dec 2018
Patient Reports of Mouth Symptoms after Radiotherapy Treatment for Head and Neck Cancer: An International Survey
People with head and neck cancer frequently have symptoms that are caused by their disease or by their treatments, which may significantly impact on…
10
Mins
6 Dec 2018
Genomic Profiling Clinical Trials in Cancer of Unknown Primary
Cancer of unknown primary (CUP) accounts for 3–5% of all cancers, and prognosis is poor for most patients, with a median survival of 6–9 months…
6 Dec 2018
Dr Mohammad Akheel
Consultant Head and Neck Oncosurgeon, Greater Kailash Hospitals, Indore, India…
←
1
2
3
…
699
700
701
702
703
704
705
…
1,061
1,062
1,063
→